KRYS Krystal Biotech, Inc.
$315.34
Krystal Biotech, Inc. (KRYS) Earnings News
Earnings press releases, previews and reviews for Krystal Biotech, Inc. (KRYS), newest first. Our most recent is review: Krystal Biotech Beats on Vyjuvek Strength and Adds a $400 Million Buyback, but Pipeline Timelines Slip Into 2027.
Monday
November 2, 2026
11:03 AM ET
Krystal Biotech Beats on Vyjuvek Strength and Adds a $400 Million Buyback, but Pipeline Timelines Slip Into 2027
Earnings Whispers · Review
Monday
November 2, 2026
7:00 AM ET
Krystal Biotech Announces Third Quarter 2026 Financial and Operating Results
Monday
October 26, 2026
11:45 AM ET
Krystal Biotech's Germany Pricing Drag Tests Whether Vyjuvek Demand Can Carry Q3
Earnings Whispers · Preview
Thursday
October 22, 2026
8:00 AM ET
Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026
Monday
August 3, 2026
7:00 AM ET
Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
Thursday
July 23, 2026
5:00 PM ET
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026